International Consolidated Airlines Group S.A (IAG)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 420.10 |
|---|---|
| 52-week range | 332.70 – 492.90 |
| Return, 1 month / 3 months | −4.3% / −0.5% |
| Return, 1 year / 3 years | +4.3% / +199.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 36.3% |
| Worst drawdown (1 year) | -25.1% |
| Average daily value traded | 4,468.26M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
International Consolidated Airlines Group is an airline holding company that owns and operates passenger carriers, including British Airways, Iberia, Aer Lingus and Vueling. It carries leisure and business travellers on short-haul and long-haul routes, and also runs cargo and maintenance operations through its airlines. The group is incorporated in Spain, with its airlines based across the United Kingdom, Spain and Ireland, and it serves destinations in Europe and other regions.
International Consolidated Airlines Group S.A trades under the code IAG on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
International Consolidated Airlines Group S.A (IAG) trades on the London Exchange in UK. It last closed at GBX 420.10 on 21 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,613 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.3% and over the last three months it fell 0.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.6% | ||
| From 52-week high | -13.9% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.5% | ||
| 6-month return | 9.8% | ||
| 12-month return, skipping the last month | 9.1% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.1% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 4,468.26M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 7 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | −4.3% |
| 3 months | −0.5% |
| 6 months | +9.8% |
| 1 year | +4.3% |
| 3 years | +199.3% |
| 5 years | +169.2% |
Signals
| 50-day / 200-day average | 426.96 / 417.74 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.56 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jun 2026 | GBP 0.0422 |
| 27 Nov 2025 | GBP 0.0405 |
| 26 Jun 2025 | GBP 0.0506 |
| 5 Sep 2024 | GBP 0.0253 |
| 2 Jul 2020 | GBP 0.2564 |
| 28 Nov 2019 | GBP 0.1844 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.